Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 116
Filtrar
1.
Intern Med J ; 45(5): 580-2, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25955464

RESUMEN

Poor outcomes are reported in young people with chronic health conditions. We performed a retrospective notes review of New Zealand paediatric liver transplant recipients transferred to adult services. Two patients were lost to follow up. Out of 20, 12 were non-adherent, and out of 12, 7 developed rejection. Other risk behaviours were common in the non-adherent group. We conclude that dedicated services for these young people may be needed to optimise outcomes.


Asunto(s)
Trasplante de Hígado , Cumplimiento de la Medicación/estadística & datos numéricos , Autocuidado/psicología , Transición a la Atención de Adultos/organización & administración , Receptores de Trasplantes/estadística & datos numéricos , Adolescente , Niño , Femenino , Estudios de Seguimiento , Humanos , Inmunosupresores/uso terapéutico , Masculino , Cumplimiento de la Medicación/psicología , Nueva Zelanda/epidemiología , Cooperación del Paciente , Pediatría , Estudios Retrospectivos , Receptores de Trasplantes/psicología , Adulto Joven
2.
J Appl Toxicol ; 34(1): 1-18, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24166207

RESUMEN

The World Health Organization/International Programme on Chemical Safety mode of action/human relevance framework has been updated to reflect the experience acquired in its application and extend its utility to emerging areas in toxicity testing and non-testing methods. The underlying principles have not changed, but the framework's scope has been extended to enable integration of information at different levels of biological organization and reflect evolving experience in a much broader range of potential applications. Mode of action/species concordance analysis can also inform hypothesis-based data generation and research priorities in support of risk assessment. The modified framework is incorporated within a roadmap, with feedback loops encouraging continuous refinement of fit-for-purpose testing strategies and risk assessment. Important in this construct is consideration of dose-response relationships and species concordance analysis in weight of evidence. The modified Bradford Hill considerations have been updated and additionally articulated to reflect increasing experience in application for cases where the toxicological outcome of chemical exposure is known. The modified framework can be used as originally intended, where the toxicological effects of chemical exposure are known, or in hypothesizing effects resulting from chemical exposure, using information on putative key events in established modes of action from appropriate in vitro or in silico systems and other lines of evidence. This modified mode of action framework and accompanying roadmap and case examples are expected to contribute to improving transparency in explicitly addressing weight of evidence considerations in mode of action/species concordance analysis based on both conventional data sources and evolving methods.


Asunto(s)
Medición de Riesgo/métodos , Pruebas de Toxicidad/métodos , Pruebas de Toxicidad/normas , Organización Mundial de la Salud , Animales , Humanos , Modelos Animales
4.
Pediatr Transplant ; 16(1): E10-4, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21054714

RESUMEN

Lymphoma is a recognized cause of liver damage and in rare instances presents as ALF. In such cases, the underlying malignancy is often difficult to detect. Historically, the prognosis has been poor. Cure has occasionally been achieved with chemotherapy alone. LT in this setting is controversial, but has contributed to successful outcomes, as in the case of the five-yr-old girl reported here.


Asunto(s)
Enfermedad de Hodgkin/terapia , Fallo Hepático Agudo/terapia , Trasplante de Hígado/métodos , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Niño , Preescolar , Femenino , Enfermedad de Hodgkin/diagnóstico , Enfermedad de Hodgkin/patología , Humanos , Linfoma/patología , Linfoma/terapia , Masculino , Persona de Mediana Edad , Recurrencia
6.
Clin Exp Dermatol ; 34(4): 495-6, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19183410

RESUMEN

Precalcaneal congenital fibrolipomatous hamartoma (PCFH) is a condition that is seldom reported in the paediatric literature and rarely in the dermatological literature. It has other disparate and confusing names and as histology is rarely obtained, the condition may be under-reported. We describe this disorder in the male twin of a pair of nonidentical twins.


Asunto(s)
Enfermedades en Gemelos/congénito , Dermatosis del Pie/congénito , Hamartoma/congénito , Enfermedades en Gemelos/patología , Dermatosis del Pie/patología , Hamartoma/patología , Talón , Humanos , Lactante , Masculino , Padres/psicología , Linaje , Gemelos
7.
Scand J Immunol ; 68(2): 153-8, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18702745

RESUMEN

X-linked lymphoproliferative (XLP) syndrome is a rare primary immune-deficiency disorder caused by mutations of the SH2D1A or XIAP genes. Males with the disorder are usually in good health until contracting Epstein-Barr virus (EBV) whereupon the majority of patients die from fulminant infectious mononucleosis, lymphoma or hypogammaglobulinaemia. This report describes a female carrier with an XLP phenotype who was retrospectively identified after her grandson died from the disorder. Subsequent genetic testing identified the patient's mother and affected maternal grandmother as XLP carriers. The family's medical records were significant. The proband had lymphoma at ages 2 and 8 and made a full recovery following treatment. Both the maternal grandmother and uncle died of non-Hodgkin's lymphoma. We were concerned that the XLP carrier mother may be predisposed to lymphoma if the normal X chromosome is skewed towards inactivation. The human androgen receptor assay detected random X chromosome inactivation in the carrier mother. EBV was not detected in the lymphoma tissues of the proband and his grandmother, confirming previous findings that EBV is not always associated with lymphoma in XLP. More significantly, our study highlights the importance of identifying XLP in families with a high incidence of lymphoma.


Asunto(s)
Heterocigoto , Péptidos y Proteínas de Señalización Intracelular/genética , Linfoma Folicular/complicaciones , Trastornos Linfoproliferativos/complicaciones , Trastornos Linfoproliferativos/genética , Adulto , Secuencia de Bases , Preescolar , Análisis Mutacional de ADN , Femenino , Humanos , Mononucleosis Infecciosa/complicaciones , Linfoma no Hodgkin/complicaciones , Linfoma no Hodgkin/genética , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Linaje , Reacción en Cadena de la Polimerasa , Proteína Asociada a la Molécula de Señalización de la Activación Linfocitaria
9.
Transplant Proc ; 38(9): 2964-7, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17112875

RESUMEN

Choice of calcineurin inhibitor may be a contributing factor to deteriorating patient and graft survival following liver transplantation for hepatitis C virus (HCV). In our multicenter, open-label LIS2T study, de novo liver transplant patients stratified by HCV status were randomized to cyclosporine or tacrolimus. Follow-up data were obtained in an observational study of 95 patients. Mean follow-up was 34 and 37 months, respectively, for cyclosporine-treated (n = 47) and tacrolimus-treated (n = 48) patients. In patients not receiving antiviral therapy, 22 of 31 given cyclosporine (72%) and 24 of 29 given tacrolimus (83%) had biochemical recurrence of HCV. In 68 patients with at least one biopsy, histological evidence of HCV-related hepatitis was present in 27 of 31 (87%) cyclosporine-treated patients and 37 of 37 (100%) tacrolimus-treated patients (P = .02, chi-square test). Three-year actuarial risk of fibrosis stage 2 was 66% with cyclosporine and 90% with tacrolimus; for fibrosis stage 3 or 4 it was 46% and 80%, respectively. Three graft losses were attributed to HCV recurrence in cyclosporine-treated patients and six in tacrolimus-treated patients. Tacrolimus may be associated with increased risk of histological HCV disease recurrence compared to cyclosporine.


Asunto(s)
Ciclosporina/uso terapéutico , Hepatitis C/cirugía , Trasplante de Hígado/fisiología , Tacrolimus/uso terapéutico , Adulto , Carcinoma Hepatocelular/cirugía , Femenino , Estudios de Seguimiento , Hepatitis C/epidemiología , Humanos , Inmunosupresores/uso terapéutico , Neoplasias Hepáticas/cirugía , Trasplante de Hígado/inmunología , Masculino , Persona de Mediana Edad , Recurrencia , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento
10.
Tissue Antigens ; 68(1): 28-37, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16774537

RESUMEN

New automated DNA sequencing technology has enabled the development of an assay for genotyping the three major HLA class 1 loci from a single sequence of each gene containing exon 3, intron 2 and exon 2. The assay allows 31 subjects (with 3 negative controls) to be genotyped at all three loci simultaneously, using a 96-well plate format. Genotypes were assigned by comparing each sequence to a database of 307 HLA-A, 563 HLA-B and 166 HLA-C alleles. Unequivocal, 4-digit allele assignments were made for 40 of 130 HLA-A genes, 82 of 130 HLA-B genes and 97 of 130 HLA-C genes from 21 European, 20 Tongan and 24 Niuean subjects. Ambiguity in interpretation of the sequence contributed to 66 of the 170 equivocal allele assignments, and 105 equivocal assignments were due to polymorphisms outside exons 2 and 3. All known alternative interpretations of ambiguous genotypes were identified, and seven HLA-B and two HLA-C ambiguities were resolved by reading the out-of-phase exon 2 sequence that followed an indel in intron 2. The genotypes of a subgroup of 27 heterozygous subjects, whose genotypes contained all of the alleles identified in this study, were confirmed with commercial, generic PCR-SSP typing. In European subjects, the repertoire of HLA-B/HLA-C haplotypes was almost identical to previously published data. We identified five new HLA-B/HLA-C haplotypes in the Polynesian subjects, and the remaining haplotypes were of Asian origin. In summary, we are describing a low-cost, sequencing assay for the three major HLA class I loci that provides a level of resolution that is comparable with a commercial PCR-SSP assay.


Asunto(s)
Genotipo , Antígenos HLA-A/genética , Antígenos HLA-B/genética , Antígenos HLA-C/genética , Análisis de Secuencia de ADN/economía , Alelos , Bases de Datos Genéticas , Femenino , Genes MHC Clase I , Haplotipos , Heterocigoto , Humanos , Polimorfismo Conformacional Retorcido-Simple , Polinesia/epidemiología , Reproducibilidad de los Resultados , Estudios Retrospectivos , Tonga/epidemiología , Población Blanca/genética
11.
Contact Dermatitis ; 54(1): 18-20, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16426288

RESUMEN

Low-molecular-weight heparins are used extensively in acute medicine. They are generally well tolerated but may cause a rare, eczema-like type IV hypersensitivity reaction. We report 3 cases of this eruption and speculate that it may be significantly under-reported due to misidentifying the causal drug, which may have serious consequences. We discuss treatment alternatives such as fondaparinux sodium, which may rarely cross-react.


Asunto(s)
Combinación Amoxicilina-Clavulanato de Potasio/efectos adversos , Antibacterianos/efectos adversos , Anticoagulantes/efectos adversos , Eccema/diagnóstico , Enoxaparina/efectos adversos , Anciano , Combinación Amoxicilina-Clavulanato de Potasio/administración & dosificación , Antibacterianos/administración & dosificación , Anticoagulantes/administración & dosificación , Diagnóstico Diferencial , Quimioterapia Combinada , Eccema/inducido químicamente , Eccema/patología , Enoxaparina/administración & dosificación , Humanos , Inyecciones Subcutáneas , Masculino , Persona de Mediana Edad , Infarto del Miocardio/tratamiento farmacológico , Trombosis de la Vena/tratamiento farmacológico , Infección de Heridas/tratamiento farmacológico
13.
BioDrugs ; 15(8): 491-500, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11543690

RESUMEN

Recipients of organ and tissue transplants require lifelong immunosuppression to prevent rejection. Better understanding of the processes culminating in allograft rejection has led to novel approaches to modulating the immune response. Co-stimulatory signals between antigen-presenting and -responding cells are essential for a normal alloimmune response, and blockade of these pathways during initial graft-host interaction may be used to ameliorate or prevent a destructive response from proceeding. A large number of experimental studies now support this concept, and early clinical trials have been initiated. Despite some early difficulties and many unanswered questions, co-stimulatory blockade has major potential as a future immune-modulating mechanism for use in clinical transplantation.


Asunto(s)
Rechazo de Injerto/inmunología , Interleucina-2/antagonistas & inhibidores , Tolerancia al Trasplante/inmunología , Animales , Rechazo de Injerto/tratamiento farmacológico , Humanos , Interleucina-2/inmunología , Tolerancia al Trasplante/efectos de los fármacos
15.
Ann Surg ; 234(2): 245-55, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11505071

RESUMEN

OBJECTIVE: To quantify the sequential changes in the metabolic response occurring in patients with end-stage liver disease after orthotopic liver transplantation (OLT). SUMMARY BACKGROUND DATA: Detailed quantification of the changes in energy expenditure, body composition, and physiologic function that occur in patients after OLT has not been performed. Understanding these changes is essential for the optimal management of these patients. METHODS: Fourteen patients who underwent OLT for end-stage liver disease had measurements of resting energy expenditure, body composition, and physiologic function immediately before surgery and 5, 10, 15, 30, 90, 180, and 360 days later. RESULTS: Resting energy expenditure was significantly elevated after surgery (24% above predicted), peaking around day 10 after OLT, when it averaged 42% above predicted. A significant degree of hypermetabolism was still present at 6 months, but at 12 months measured resting energy expenditure was close to predicted values. Before surgery, measured total body protein was 82% of estimated preillness total body protein. During the first 10 days after OLT, a further 1.0 kg (10%) of total body protein was lost, mostly from skeletal muscle. Only 54% of this loss was restored by 12 months. Significant overhydration of the fat-free body was seen before OLT, and it was still present 12 months later. Although significant losses of body fat and bone mineral occurred during the early postoperative period, only body fat stores were restored at 12 months. Both subjective fatigue score and voluntary hand grip strength improved rapidly after OLT to exceed preoperative levels at 3 months. At 12 months grip strength was close to values predicted for these patients when well. Respiratory muscle strength improved less markedly and was significantly lower than predicted normal levels at 12 months. CONCLUSIONS: Before surgery, these patients were significantly protein-depleted, overhydrated, and hypermetabolic. After surgery, the period of hypermetabolism was prolonged, restoration of body protein stores was gradual and incomplete, and respiratory muscle strength failed to reach expected normal values. Our measurements indicate that OLT does not normalize body composition and function and imply that a continuing metabolic stress persists for at least 12 months after surgery.


Asunto(s)
Metabolismo Energético/fisiología , Fallo Hepático/cirugía , Trasplante de Hígado/fisiología , Adolescente , Adulto , Composición Corporal/fisiología , Femenino , Estudios de Seguimiento , Humanos , Fallo Hepático/fisiopatología , Masculino , Persona de Mediana Edad , Fatiga Muscular/fisiología , Complicaciones Posoperatorias/fisiopatología
17.
Clin Exp Dermatol ; 26(3): 251-5, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11422167

RESUMEN

Eosinophilic pustular folliculitis (EPF) of infancy is a rare disorder which may begin in the neonatal period and cause considerable parental anxiety. It must be distinguished from other causes of a pustular eruption in neonates, including infection and erythema toxicum neonatorum, and rare disorders such as transient neonatal pustular melanosis, infantile acropustulosis and Langerhans' cell histiocytosis. Skin smears and occasionally skin biopsy may be necessary to reach a diagnosis. We report a case of a Caucasian child with an unusually early onset of EPF in the first day of life. We wish to emphasize the importance of recognizing this self-limiting condition in order to prevent inappropriate antimicrobial treatment.


Asunto(s)
Eosinofilia/diagnóstico , Foliculitis/diagnóstico , Diagnóstico Diferencial , Eosinofilia/patología , Femenino , Foliculitis/patología , Estudios de Seguimiento , Humanos , Recién Nacido
19.
Clin Exp Dermatol ; 26(2): 162-5, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11298106

RESUMEN

We describe two patients, who presented with erythematous facial plaques, in keeping with neutrophilic eccrine hidradenitis, during chemotherapy for acute myeloid leukaemia. Both patients were neutropaenic and febrile. Histology showed a dermal neutrophilic infiltrate around the eccrine glands with gland destruction. The importance of recognizing this disorder is to prevent the inappropriate use of antibiotics as it is self limiting.


Asunto(s)
Hidradenitis/diagnóstico , Enfermedad Aguda , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Citarabina/administración & dosificación , Daunorrubicina/administración & dosificación , Etopósido/administración & dosificación , Femenino , Hidradenitis/complicaciones , Humanos , Leucemia Mieloide/complicaciones , Leucemia Mieloide/tratamiento farmacológico , Mitoxantrona/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA